Danielle Keatley
Investor Relations Contact bei STRUCTURE THERAPEUTICS INC.
Profil
Danielle Keatley is currently the Head-Investor Relations at Structure Therapeutics, Inc. Previously, she worked as the Head-Media Relations at Onyx Pharmaceuticals, Inc. from 2012 to 2013.
She also served as the Head-IR & Corporate Communications at Ultragenyx Pharmaceutical, Inc. from 2016 to 2021.
Aktive Positionen von Danielle Keatley
Unternehmen | Position | Beginn |
---|---|---|
STRUCTURE THERAPEUTICS INC. | Investor Relations Contact | - |
Ehemalige bekannte Positionen von Danielle Keatley
Unternehmen | Position | Ende |
---|---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Investor Relations Contact | 01.08.2021 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Public Communications Contact | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
STRUCTURE THERAPEUTICS INC. | Commercial Services |
Private Unternehmen | 1 |
---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |